A crucial aspect of regenerative healthcare and drug research lies in the ability to expand human stem cell collections to sufficient quantities for therapeutic uses. Traditionally, limited cell availability posed a significant obstacle to progress in these fields. Consequently, considerable effort has been directed towards optimizing procedures fo